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Cell kinetics and cancer therapy. JULIANA
DENEKAMP, USA, Charles C. Thomas, 162 pp,
1982, $24.75.
This book provides a concise and extremely well-
written account of the likely importance of cell
proliferation kinetics, in tumours and normal
tissues, as applied to radiation oncology. The book
is clearly illustrated with good referencing to most
aspects of scientific detail. The 12 pages of
bibliography make it a useful reference book to
someone entering this field. The reader might be
left with the feeling, from the captions to figures
and the bibliography, that most contributions in the
field covered by this book have come from the
Gray Laboratory. The author should make no
apologies for this as she does indicate, in her
acknowledgement of the financial support provided
by the Cancer Research Campaign, that the book
was intended as a synopsis of the ideas and data
collected over her time there. The broad spectrum
of topics covered is an indication of the
contribution which the Gray Laboratory has made
to cancer research over the last decade.
The book is divided into several sections and it
would be hard to say that any one was
outstandingly better than another. However, the
one on the analysis of proliferation parameters and
the section on tumour growth in experimental
animals are particularly good. The information
available on the growth and kinetics of human
tumours is extremely limited, but all the data that
are available are discussed in context and compared
with the more extensive animal tumour data. To all
those new to a field it is always helpful to have an
insight into the presently appreciated limitations of
animal models. This book does this reasonably
well. Chapters on the influence of radiation on
proliferation patterns and on the effects of cell
kinetics on the response of tissues to radiation
provide a good review of present knowledge on
these topics.
The concluding chapter on growing points in
radiation therapy was a little disappointing with no
really new or up-to-date ideas presented. However,
this is probably more a reflection of the time taken
between writing and publication of the book than
criticism of the author.
It is extremely hard to fault this book; however,
a number of small comments would appear to be
not out of place in a book of this type. These relate
to the speed and particularly the economy of
experiments carried out on rapidly-proliferating
rodent tumours compared with the extremely
expensive maintenance costs and strain on the
patience of workers of long term studies on slow-
growing tumours. All investigators like to acquire
quick results, but if long term studies are clinically
relevant they need to be undertaken even if the
costs are higher and the overall rate of "progress"
reduced.
I would recommend this book both to the young
researcher, the trainee oncologist and to all
involved in teaching in this field.
J. HOPEWELL




Non-Steroidal Antioestrogens. R.L. SUTHERLAND &
V. CRAIG JORDAN, New York, Academic Press,
Inc., 486 pp, 1982, $68.00.
This is an excellent book and I recommend it to
anyone interested in the action of both oestrogens
and antioestrogens in normal or malignant tissues.
The discovery and the use in the clinic of the
antioestrogens clomiphene and tamoxifen has led to
much research into their pharmacology and
mechanism of action. The editors have presented a
summary of the wealth of information now
available by inviting acknowledged leaders in the
field to contribute to the book. I suggest that
readers turn to the last chapter first; this is written
by the editors, Drs. Sutherland and Jordan and
provides a concise picture of the present level of
understanding of the mechanism by which synthetic
non-steroid antioestrogens antagonise the effect of
oestrogen; they indicate which chapters are devoted
to particular aspects of these studies in animal
models, in cultured cell lines and in human
tumours. The editors make the important point that
there are large species differences in the biological
properties of these compounds so it is impossible to
have a single simple definition of an antioestrogen,
nor do they think it likely that there is a single
fundamental mechanism of action. In their
conclusion the future prospects of the work are
discussed and one is left with the exciting
impression that much more information will soon
be available following the development of new
antioestrogens. The successful treatment of human
breast cancer with these compounds is reported in
several chapters and with increased understanding166 BOOK REVIEWS
of the molecular mechanisms of action there will
hopefully be further improvements in the control of
this disease.
Having read this book I expect that people will
eagerly await the second edition.
D. BARNES,
Department of Endocrinology,
Christie Hospital & Holt
Radium Institute,
Manchester.
Markers for the diagnosis and monitoring of human
cancer: Serono Symposium No. 46. M.I.
COLNAGHI, G.L. BURAGGI & M. GHIONE.
Academic Press, London, 280 pp, 1982, $21.60.
This book provides a collection of chapters and
expert opinion in the form of discussion sections
which comprise the Proceedings of a conference
held in March 1981 in Milan. The topics covered
provide a comprehensive guide to the state of the
art on markers for major tumour sites, (e.g. breast
and large intestine) as well as a series of less
frequent tumours, pancreas, prostate, ovary and
testicular cancers. Apart from the site-orientated
presentations there are several papers describing the
use and limitations of serum ferritin levels,
circulating immune complexes and several other
non-specific tests. An important part of the book is
the description of many biochemical phenomena
associated with cancer as well as the technological
aspects of the isolation of putative markers and the
development of appropriate immunochemical
assays.
The overview suggests that it is only in a few
tumours that specific sensitive markers have
emerged. However, the research has undoubtedly
provided biochemical stratification both of the
tumour cells and the host's reactions to tumour
that can provide information that is additive to the
well-established clinical and pathological criteria for
predicting survival.
E.H. COOPER
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